Lynne Chou O'Keefe is Director at Hims & Hers Health, Inc. (HIMS). They have made 5 open-market trades across 1 company since 2022, most recently 2024-06-06.
CIK 0001837800
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HIMS | 19,707 | $525K |
Shares reported on the most recent Form 4, priced at the 2024-06-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HIMS | SELL · 10b5-1 | 2024-03-19 | 2024-03-19 | $15.52 | $312K | -0.7% | -21.8% | +53.1% |
| HIMS | SELL · 10b5-1 | 2023-12-19 | 2023-12-20 | $8.73 | $175K | +7.6% | -1.1% | +86.0% |
| HIMS | SELL · 10b5-1 | 2023-09-19 | 2023-09-20 | $6.31 | $127K | +6.1% | -1.3% | +43.9% |
| HIMS | SELL · 10b5-1 | 2023-08-14 | 2023-08-16 | $7.15 | $654K | -2.0% | -9.7% | +5.3% |
| HIMS | SELL | 2022-12-19 | 2022-12-20 | $6.72 | $135K | -6.0% | +11.3% | +43.8% |
| HIMS | SELL | 2022-09-20 | 2022-09-21 | $5.68 | $114K | -0.7% | -22.0% | +18.8% |
| HIMS | SELL | 2022-06-21 | 2022-06-22 | $4.35 | $44K | +16.0% | +33.1% | +30.6% |
| HIMS | SELL | 2022-03-17 | 2022-03-18 | $4.50 | $45K | +5.6% | -4.2% | -18.7% |
| HIMS | SELL | 2022-03-02 | 2022-03-03 | $5.04 | $405K | -9.8% | +14.6% | -16.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.